SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. It offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. The company also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products comprise Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.

CEO

Mr. Andreas Reisse

Employees

4775

Country

ISIN

US8080381036

WKN

000A40AE0

Listings

0 Comments

Share your thoughts

FAQ

What is Schott Pharma & CO. stock price today?▼

The current price of 1SX.F is €3.18 EUR — it has decreased by -1.85% in the past 24 hours. Watch Schott Pharma & CO. stock price performance more closely on the chart.

What is Schott Pharma & CO. stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Schott Pharma & CO. stocks are traded under the ticker 1SX.F.

Is Schott Pharma & CO. stock price growing?▼

1SX.F stock has risen by +0.63% compared to the previous week, the month change is a -5.36% fall, over the last year Schott Pharma & CO. has showed a -34.57% decrease.

When is the next Schott Pharma & CO. earnings date?▼

Schott Pharma & CO. is going to release the next earnings report on May 13, 2026.

What were Schott Pharma & CO. earnings last quarter?▼

1SX.F earnings for the last quarter are 0.22 EUR per share, whereas the estimation was 0.17 EUR resulting in a +24.37% surprise. The estimated earnings for the next quarter are N/A EUR per share.

What is Schott Pharma & CO. revenue for the last year?▼

Schott Pharma & CO. revenue for the last year amounts to 1.97B EUR.

What is Schott Pharma & CO. net income for the last year?▼

1SX.F net income for the last year is 292.91M EUR.

Does Schott Pharma & CO. pay dividends?▼

Yes, 1SX.F dividends are paid annual. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (FWD)% is 1.41%.

How many employees does Schott Pharma & CO. have?▼

As of April 07, 2026, the company has 4,775 employees.

When did Schott Pharma & CO. complete a stock split?▼

Schott Pharma & CO. has not had any recent stock splits.

Where is Schott Pharma & CO. headquartered?▼

Schott Pharma & CO. is headquartered in Mainz, DE.